Cargando…
De novo design of picomolar SARS-CoV-2 miniprotein inhibitors
Targeting the interaction between the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein and the human angiotensin-converting enzyme 2 (ACE2) receptor is a promising therapeutic strategy. We designed inhibitors using two de novo design approaches. Computer-generated scaffolds...
Autores principales: | Cao, Longxing, Goreshnik, Inna, Coventry, Brian, Case, James Brett, Miller, Lauren, Kozodoy, Lisa, Chen, Rita E., Carter, Lauren, Walls, Alexandra C., Park, Young-Jun, Strauch, Eva-Maria, Stewart, Lance, Diamond, Michael S., Veesler, David, Baker, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857403/ https://www.ncbi.nlm.nih.gov/pubmed/32907861 http://dx.doi.org/10.1126/science.abd9909 |
Ejemplares similares
-
Ultrapotent miniproteins targeting the receptor-binding domain protect against SARS-CoV-2 infection and disease in mice
por: Case, James Brett, et al.
Publicado: (2021) -
Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and disease
por: Case, James Brett, et al.
Publicado: (2021) -
Improving de novo protein binder design with deep learning
por: Bennett, Nathaniel R., et al.
Publicado: (2023) -
De novo design of highly selective miniprotein inhibitors of integrins αvβ6 and αvβ8
por: Roy, Anindya, et al.
Publicado: (2023) -
De novo design of highly selective miniprotein inhibitors of integrins αvβ6 and αvβ8
por: Roy, Anindya, et al.
Publicado: (2023)